JP2014522388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014522388A5 JP2014522388A5 JP2014506792A JP2014506792A JP2014522388A5 JP 2014522388 A5 JP2014522388 A5 JP 2014522388A5 JP 2014506792 A JP2014506792 A JP 2014506792A JP 2014506792 A JP2014506792 A JP 2014506792A JP 2014522388 A5 JP2014522388 A5 JP 2014522388A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- acetamide
- naphthyl
- methoxy
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 claims 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims 4
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 claims 3
- -1 7-methoxy-1-naphthyl Chemical group 0.000 claims 2
- 238000001069 Raman spectroscopy Methods 0.000 claims 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 229960002629 agomelatine Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11075073.4A EP2517700B1 (en) | 2011-04-28 | 2011-04-28 | Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation |
| EP11075073.4 | 2011-04-28 | ||
| PCT/EP2012/001761 WO2012146371A1 (en) | 2011-04-28 | 2012-04-25 | Pharmaceutically acceptable cocrystals of n-[2-(7-methoxy-1-naphtyl)ethyl]acetamide and methods of their preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014522388A JP2014522388A (ja) | 2014-09-04 |
| JP2014522388A5 true JP2014522388A5 (enExample) | 2015-05-28 |
| JP5770928B2 JP5770928B2 (ja) | 2015-08-26 |
Family
ID=44519907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014506792A Expired - Fee Related JP5770928B2 (ja) | 2011-04-28 | 2012-04-25 | Ｎ‐［２‐（７‐メトキシ‐１‐ナフチル）エチル］アセトアミドの医薬的に許容される共結晶及びそれらの調製方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8927771B2 (enExample) |
| EP (1) | EP2517700B1 (enExample) |
| JP (1) | JP5770928B2 (enExample) |
| KR (1) | KR20140008370A (enExample) |
| CN (1) | CN103501777B (enExample) |
| BR (1) | BR112013023471A2 (enExample) |
| EA (1) | EA024422B1 (enExample) |
| ES (1) | ES2429348T3 (enExample) |
| IL (1) | IL228916A (enExample) |
| MX (1) | MX342807B (enExample) |
| PL (1) | PL2517700T3 (enExample) |
| PT (1) | PT2517700E (enExample) |
| RS (1) | RS52982B (enExample) |
| UA (1) | UA111844C2 (enExample) |
| WO (1) | WO2012146371A1 (enExample) |
| ZA (1) | ZA201307688B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012000132B1 (en) | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
| EP2551257A1 (en) * | 2011-07-28 | 2013-01-30 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of agomelatine with co-crystal-formers |
| EP2851363B1 (en) | 2012-05-14 | 2018-01-03 | Shanghai Righthand Pharmtech. Co., Ltd. | Agomelatine acid radical composite, and preparation method and application thereof |
| US10098859B2 (en) | 2012-09-05 | 2018-10-16 | Amri Ssci, Llc | Cocrystals of p-coumaric acid |
| ES2590908T3 (es) | 2012-12-17 | 2016-11-24 | Dr. Reddy's Laboratories Ltd. | Cocristal de agomelatina con ácido fosfórico |
| PL2810656T3 (pl) | 2013-06-06 | 2018-01-31 | Zentiva Ks | Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów |
| EP2810647A1 (en) * | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
| HK1223088A1 (zh) | 2013-07-29 | 2017-07-21 | Les Laboratoires Servier | 阿戈美拉汀和磺酸的新复合物、其制备方法和包含其的药物组合物 |
| WO2015013865A1 (en) * | 2013-07-29 | 2015-02-05 | Les Laboratoires Servier | Agomelatine sulfonic acids complexes and preparation thereof |
| FR3012142B1 (fr) * | 2013-10-17 | 2016-07-15 | Servier Lab | Nouveaux complexes d'agomelatine et d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN105473551B (zh) * | 2013-07-31 | 2019-01-11 | 法国施维雅药厂 | 阿戈美拉汀和对甲苯磺酸的共晶的新形式、其制备方法和包含其的药物组合物 |
| WO2015013903A1 (en) * | 2013-07-31 | 2015-02-05 | Les Laboratoires Servier | NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THEREOF |
| ES2734562T3 (es) * | 2013-07-31 | 2019-12-10 | Servier Lab | Co-cristales de agomelatina y ácido p-toluensulfónico, su procedimiento de preparación y composiciones farmacéuticas que los contienen |
| KR101404836B1 (ko) | 2014-03-21 | 2014-06-09 | 순천향대학교 산학협력단 | 아고멜라틴의 공결정 및 그의 제조방법 |
| KR101470794B1 (ko) * | 2014-06-30 | 2014-12-08 | 순천향대학교 산학협력단 | 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물 |
| PL3075724T3 (pl) | 2015-03-31 | 2023-12-27 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Stała postać agomelatyny |
| WO2017115284A1 (en) * | 2015-12-28 | 2017-07-06 | Leiutis Pharmaceuticals Pvt, Ltd. | Novel co-crystal forms of agomelatine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2514733A1 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| AR047553A1 (es) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina |
| WO2008035177A2 (en) * | 2006-09-18 | 2008-03-27 | Copharm | Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor |
| CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
| CN102106806B (zh) * | 2009-12-29 | 2013-04-17 | 上海中西制药有限公司 | 一种固体制剂的制备方法及所得固体制剂 |
| WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
| PH12012000132B1 (en) * | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
-
2011
- 2011-04-28 RS RS20130436A patent/RS52982B/sr unknown
- 2011-04-28 EP EP11075073.4A patent/EP2517700B1/en not_active Not-in-force
- 2011-04-28 ES ES11075073T patent/ES2429348T3/es active Active
- 2011-04-28 PT PT110750734T patent/PT2517700E/pt unknown
- 2011-04-28 PL PL11075073T patent/PL2517700T3/pl unknown
-
2012
- 2012-04-25 BR BR112013023471A patent/BR112013023471A2/pt not_active Application Discontinuation
- 2012-04-25 EA EA201391574A patent/EA024422B1/ru not_active IP Right Cessation
- 2012-04-25 CN CN201280020790.9A patent/CN103501777B/zh not_active Expired - Fee Related
- 2012-04-25 MX MX2013012103A patent/MX342807B/es active IP Right Grant
- 2012-04-25 WO PCT/EP2012/001761 patent/WO2012146371A1/en not_active Ceased
- 2012-04-25 UA UAA201313793A patent/UA111844C2/uk unknown
- 2012-04-25 US US14/114,211 patent/US8927771B2/en not_active Expired - Fee Related
- 2012-04-25 KR KR1020137024023A patent/KR20140008370A/ko not_active Ceased
- 2012-04-25 JP JP2014506792A patent/JP5770928B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-16 ZA ZA2013/07688A patent/ZA201307688B/en unknown
- 2013-10-16 IL IL228916A patent/IL228916A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013049690A5 (enExample) | ||
| RU2015100280A (ru) | Многокомпонентные кристаллы, содержащие дазатиниб и определенные сокристаллобразователи | |
| JP2017522276A5 (enExample) | ||
| FI4293009T3 (fi) | Fenfluramiinikoostumukset ja menetelmät niiden valmistamiseksi | |
| RU2013158816A (ru) | Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат | |
| JP2013503134A5 (enExample) | ||
| JP2007532560A5 (enExample) | ||
| JP2013520488A5 (enExample) | ||
| CN103570508B (zh) | 一种反式白藜芦醇的全合成方法 | |
| JP2019529553A5 (enExample) | ||
| JP2011527986A5 (enExample) | ||
| HRP20191880T1 (hr) | Novi postupak | |
| RU2019106531A (ru) | Кристалл соли производного хиназолина | |
| RU2016134404A (ru) | КРИСТАЛЛИЧЕСКАЯ ФОРМА α МОНОБЕНЗОАТА СОЕДИНЕНИЯ А, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЕ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ | |
| CN105111244B (zh) | 二茂铁氧桥双环‑[2．2．1]‑庚烯类化合物 | |
| JP5984988B2 (ja) | （＋）および（−）−１−（３，４−ジクロロフェニル）−３−アザビシクロ［３．１．０］ヘキサンの合成のための方法 | |
| JP2019512542A5 (enExample) | ||
| JP2018502165A5 (enExample) | ||
| HRP20250660T1 (hr) | Čvrsti oblici ixazomib citrata | |
| MD20120130A2 (en) | Delta crystalline form of the L-arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it | |
| JP2020503330A5 (enExample) | ||
| JP2010540440A5 (enExample) | ||
| CN103641674A (zh) | 一种二芳基砜的制备方法 | |
| CN101709050A (zh) | 合成2,5-二氯吡啶的新方法 | |
| RU2018111482A (ru) | Кристаллические формы бедаквилин фумарата и способы их получения |